相关期刊:《Chinese Journal of Integrative Medicine》《Journal of Hainan Medical University》《Advances in Modern Oncology Research》《International Journal of Ophthalmology(English edition)》更多>>
Supported by the National Natural Science Foundation of China(No. 81573315), the Natural Science Foundation of Guangdong Province, China(No.2015A030313313), the Guangzhou Industry-University Collaborative Innovation Major Projects, China(No.201508030016) and the Natural Science Foundation of Hainan Province, China(No.817307).
Two series of novel spin-labeled derivatives of Cinobufagin(compounds 5 and 8a--8f in series 1 with five-membered ring nitroxyl free radical and compounds 6 and 9a-9f in series 2 with six-membered ring nitroxyl free ...
Supported by the National Natural Science Foundation of China(No.81573315), the Guangdong Natural Science Fund, China(No.2015A030313313) and the Guangzhou Industry-University Collaborative Innovation Major Projects, China(No. 201508030016).
Some cinobufagin oxime ether derivatives as potential Na+/K+-ATPase inkibitors were synthesized by following the side chain of istaroxime. These compounds inhibit Na+/K+-ATPase in a dose-dependent manner. Compound...
In this paper, cinobufagin and resibufogenin were found to inhibit enterovirus 71(EV71) infection in vitro in cell viability and plaque reduction assays. The 50% inhibitory concentrations(lCs0) of einobufagin and ...
Supported by the National Natural Science Foundation of China(Nos.30772721 and 30873360)
In vitro models of human colon carcinoma cell line(Caco-2 cell monolayer) and human intestinal bacteria were used to investigate the intestinal transport and biotransformation of resibufogenin and cinobufagin in Chan ...